Moderna’s SARS-CoV-2 Vaccine’s Fast Track to Clinical Trials

The holy grail of the current pandemic—a vaccine for COVID-19—will not be available next month. It may not even be ready by next year. Regardless, the strides being made are happening at unprecedented speed....

Helping Biosimilars Emerge into Global Markets Takes a Practiced Hand

/* custom css */ .td_uid_1_5e666172a2062_rand { min-height: 0; } /* custom css */ .td_uid_2_5e666172a22b1_rand { vertical-align: baseline; } Currently, almost 60 percent of drugs in development are being created by emerging biotech companies focused on therapies...

At Suburban N.Y. Campus, BioMed Realty Thinks Small

The development surge for up-and-coming life sciences companies now occurring in New York City is also unfolding in suburban Westchester County, where representatives of two life-sci lab space projects addressed a coalition of industry...

At Laboratory for Advanced Medicine, New CEO Sharpens Commercial Focus

With a new CEO at the helm, the Laboratory for Advanced Medicine (LAM) is preparing for the launch of its first liquid biopsy—a blood test designed to detect early-stage liver cancer, expected to win...

Alzheimer’s Disease and Tau Tangle Proteinopathies Linked to Protein that Prevents Tau Clearance

Studies by researchers at University of South Florida Health (USF Health) Morsani College of Medicine have found that a protein known as β-arrestin2 increases the accumulation of the neurotoxic tau tangles that cause several...

Prebiotics Boost Antitumor Immunity and Help Mice Fight Melanoma

Studies by scientists at Sanford Burnham Prebys Medical Discovery Institute showed that feeding mice with two prebiotics, mucin and inulin, boosted the immune system’s ability to fight cancer, slowed the growth of implanted melanoma...

Going Gray Too Soon? Scientists Say It Really May Be Due to Stress

Stress has long been anecdotally linked with prematurely graying hair. It’s said, for example, that when Marie Antoinette was captured during the French Revolution, her hair turned white overnight. Anecdote this may be, but...

Roche Buys Ex-U.S. Rights to Sarepta DMD Gene Therapy Candidate SRP-9001 for Up-to-$2.85B+

Roche has acquired exclusive commercial rights outside the United States to Sarepta Therapeutics’ lead gene therapy pipeline candidate SRP-9001 (AAVrh74.MHCK7.micro-dystrophin) for Duchenne muscular dystrophy (DMD), through a licensing agreement that could generate more than...

Nanoscale Gimlet May Give Weakened Antibiotics a Kick

A two-ingredient antibacterial cocktail is more potent than either ingredient alone, even though one of the ingredients is meropenem, an antibiotic that induces multidrug resistance in bacteria. This surprising outcome depends on a twist—or...

Antibody Drug Conjugates: Manufacturing Precision Guided Therapeutics

/* custom css */ .td_uid_1_5dd8dc1e8c755_rand { min-height: 0; } /* custom css */ .td_uid_2_5dd8dc1e8c9d6_rand { vertical-align: baseline; } While the idea of a magic bullet that treats all maladies is a concept grounded in antiquity, antibody...